Tradestie Institutional Equity Comparison Engine
AXNX vs SIBN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SIBN Overall Edge
SIBN Captures Institutional Edge (3โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SI-BONE, Inc. Common Stock (SIBN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SIBN at N/M Forward P/E and -7.6% operating margin (+14.5% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SIBN sits in BREAKOUT (48th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AXNX N/M vs SIBN N/M Fwd P/E
Growth & Margin Winner
SIBN
Op Margin N/A vs -7.6% ยท YoY N/A vs +14.5%
Momentum & Technical Winner
SIBN
1Y +16.9% vs +27.6% ยท 52W Pos 50% vs 85%
Options & Structure Winner
SIBN
UNCLASSIFIED (N/A IV) vs BREAKOUT (48th %ile IV)
AXNX
US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap
N/A
1M Return
-26.54%
1Y Return
+16.92%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
SIBN
NASDAQ
SI-BONE, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$23.73
-0.08% 1D
Market Cap
$1.1B
1M Return
+10.06%
1Y Return
+27.58%
Forward P/E
N/M
Unified AI Score
53.5 / 100
HOLD
Tech 45.0
Fund 57.0
Flow 72.0
Mom 56.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AXNX +16.92%
SIBN +27.58%
Spread: +3.66 pp (SIBN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AXNX TTM Op. Margin: N/A
SIBN TTM Op. Margin: -7.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs SIBN. Trailing 12-month operating profitability (AXNX N/A vs SIBN -7.6%) and valuation multiples (AXNX N/M vs SIBN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXNX | SIBN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.1B | Larger Scale | SIBN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +14.5% | Higher Growth | SIBN |
| Operating Margin (TTM) Profitability | N/A | -7.6% | Higher Margin | SIBN |
| Net Profit Margin Profitability | N/A | -6.2% | Higher Margin | SIBN |
| Return on Equity (ROE) Capital Efficiency | N/A | -7.7% | Higher ROE | SIBN |
| 52-Week Range Position Momentum | 50% ($0โ$1) | 85% ($11โ$26) | Stronger Trend | SIBN |
| Beta / 30D Volatility Risk Regime | N/A | 0.65ฮฒ ยท 74% Vol | Lower Realized Risk | SIBN |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 53.5 / 100 (HOLD) | Higher Composite | SIBN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AXNX vs SIBN Buy Guide
AXNX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SIBN
BREAKOUT
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
48th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AXNX nor SIBN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.